CUSIP H0036K147SHSADCTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
113 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Redmile Group, LLC | 15.67M | $55.30M | 0 | Held |
| 2 | Tcg Crossover Management, LLC | 11.39M | $40.21M | +10.00M | Added |
| 3 | Prosight Management, LP | 8.48M | $29.93M | +1.01M | Added |
| 4 | Orbimed Advisors LLC | 5.82M | $20.55M |
| −84.5K |
| Reduced |
| 5 | Nantahala Capital Management, LLC | 5.48M | $19.33M | +3.21M | Added |
| 6 | Blackrock, Inc. | 5.43M | $19.16M | +915.6K | Added |
| 7 | Point72 Asset Management, L.P. | 5.01M | $17.70M | −3.12M | Reduced |
| 8 | Morgan Stanley | 3.77M | $13.31M | +100.7K | Added |
| 9 | Eventide Asset Management, LLC | 3.36M | $11.88M | +3.36M | New |
| 10 | Goldman Sachs Group Inc | 1.64M | $5.79M | +46.4K | Added |
See every fund holding Adc Therapeutics SA, with full quarter-over-quarter share changes.
Unlock all holders